UIM
BNTX icon

USS Investment Management’s BioNTech BNTX Stock Holding History

USS Investment Management’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.8M Buy
51,109
+18,532
+57% +$1.74M 0.02% 427
2026
Q1 		$2.85M Buy
32,577
+382
+1% +$39.3K 0.01% 448
2025
Q4 		$3.07M Buy
32,195
+4,373
+16% +$441K 0.01% 448
2025
Q3 		$2.74M Hold
27,822
– – 0.01% 462
2025
Q2 		$2.97M Hold
27,822
– – 0.02% 451
2025
Q1 		$2.53M Sell
27,822
-28
-0.1% -$3.13K 0.02% 460
2024
Q4 		$3.12M Buy
+27,850
New +$3.18M 0.02% 464

Other funds holding BNTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
GP
GSK plc London $602M AUM

USS Investment Management's BNTX Position: Q2 2026 in Review

USS Investment Management increased its BioNTech (BNTX) stake by 57% in Q2 2026, buying an estimated $1.74M and bringing the position to 51,109 shares worth $4.8M. The position accounts for 0.02% of the portfolio, ranked #427.

USS Investment Management first reported a position in BNTX in Q4 2024 and has held it in 7 quarters since. 282 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.

  • USS Investment Management held 51,109 shares of BioNTech worth $4.8M as of Q2 2026.
  • USS Investment Management bought 18,532 BioNTech shares in Q2 2026, an estimated $1.74M.
  • BioNTech made up 0.02% of USS Investment Management's portfolio in Q2 2026, its #427 holding.
  • USS Investment Management first reported a position in BioNTech in Q4 2024 and has held it in 7 quarters since.
  • 282 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.

Based on USS Investment Management's 13F filing for Q2 2026, filed 11 Aug 2026.